Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 12Neoplasms 7cyclopia sequence 6Polycystic Ovary Syndrome 4Fatigue 4Obesity 3Multiple Myeloma 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms, Plasma Cell 2Hematologic Diseases 2Head and Neck Neoplasms 2Depression 2Weight Loss 1Warts 1Vomiting 1Vitamin D Deficiency 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Sleepiness 1Sezary Syndrome 1Prostatic Intraepithelial Neoplasia 1Primary Myelofibrosis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Sugars × Clear all
NCT01489813 2025-02-05

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

Emory University

Phase 2 Completed
36 enrolled 7 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡